In this issue of Urologic Clinics of North America, guest editor Dr. Adam Feldman brings his considerable expertise to the topic of Biomarkers in Urology. The use of biomarkers in clinical practice can range from screening, to refined detection in an at-risk population, to risk stratification following diagnosis, to prognostication following therapy. A better understanding of tumor biology and genetic heterogeneity will lead clinicians to adopt clinical paradigms that utilize sequences of biomarker assessments. In this issue, key experts help you remain at the forefront of the care of urologic malignancies by providing a timely update on emerging biomarkers in urology.
- ISBN: 978-0-323-94019-1
- Editorial: Elsevier
- Encuadernacion: Cartoné
- Páginas: 240
- Fecha Publicación: 28/02/2023
- Nº Volúmenes: 1
- Idioma: Inglés